Nevertheless, an early study showed that specific inhibition of NF-κB by overexpression of IκBα-SR had no significant impact on GBM cell apoptosis induced by TRAIL, implying that the characteristic anti-apoptotic function of NF-κB in many cancers is not a primary feature for GBM [78]. The gene discussed is NFKB1; the disease is cancer.